Agenda for International Development
As we launch a brand-new section of our union, the Association for Development and Diplomacy, we wanted to take stock and look at the competing priorities and challenges to the international development agenda.
Last year, one of the most dramatic changes to government structure occurred when the Foreign and Commonwealth Office (FCO) merged with the Department for International Development (DFID) to form the Foreign, Commonwealth and Development Office (FCDO).
The announcement and subsequent merger saw a wide variety of reactions from charities, NGOs, academics and civil servants. For some, it was seen as an opportunity for the UK to have an even greater impact and influence on the rest of the world. However, many are unsure about the implications of the merger, both now and in the future. The recent reduction in the aid budget from 0.7 to 0.5% of Gross National Income (GNI) further complicates the picture and there are serious concerns that this will hinder the work of charities and NGOs, and potentially impact the UK’s global reputation.
This report looks at a range of issues connected with the development agenda, from the impact of the merger on the working lives of our civil servants to wider international developments on climate, trade and health.
Agenda for International Development by FDAunion on Scribd
Related News
-
FDA condemns dismissal of Sir Olly Robbins over Mandelson vetting
The FDA has condemned the Prime Minister’s dismissal of Sir Olly Robbins, former FCDO Permanent Secretary, over the vetting of Lord Mandelson for his appointment as Ambassador to the United States.
-
Never again
Following the unacceptable issues arising from the civil service pension scheme transfer to Capita, Adrian Prandle outlines the FDA’s ongoing work to ensure members get the support they need as quickly as possible.
-
Shaping the world of work: Dave Penman on the challenges facing the civil service, and plans for his new term as General Secretary
Following his re-election, Dave Penman outlines the challenges of the next five years and his plans to improve the working lives of FDA’s members.
